1Aksungar FB, Topkaya AE, Yildiz Z, et al. Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci, 2008, 15 : 393 -397.
2Green D, Foiles N, Chan C, et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study, Atherosclerosis, 2008, doi: 10. 1016/j. atherosclerosis. 2008.05. 039.
3Sabeti S, Exner M, Mlekusch W, et al. Prognostic impact of fibrinogen in carotid atherosclerosis. Stroke, 2005, 36 : 1400 - 1404.
4Sagastagoitia JD, Saez Y, Vacas M, et al. Association between inflammation, lipid and hemostatic factors in patients with stable angina. Thromb Res, 2007, 120 : 53 -59.
5Susan T. Fibrinogen and fibrin: scaffold proteins in hemosta- sis. Curr Opin Hematol. 2007, 14 : 236 -241.
6Ajjan R, Grant PJ. Coagulation and atherothrombotic disease. Atherosclerosis, 2006, 186 : 240 -259.
7Tzoulaki L, Murray GD, Price JF, et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis. Am J Epidemiol, 2006, 163 : 334 -341.
8Tyagi N, Roberts AM, Dean WL, et al. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem, 2008, 307 : 13 -22.
9Zhou D, Yang PY, Zhou B, et al. Fibrin D-dimer fragments enhance inflammatory responses in macrophages: role in advancing atherosclerosis. Clin Exp Pharmacol Physiol, 2007, 34 : 185- 190.
10Rauch B, Muschenborn B, Braun M,et al. ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cells. Eur J Pharmacol, 2007,577 : 54 - 57.
